Vanadyl sulfate inhibits NO production via threonine phosphorylation of eNOS.

dc.contributor.author

Li, Zhuowei

dc.contributor.author

Carter, Jacqueline D

dc.contributor.author

Dailey, Lisa A

dc.contributor.author

Huang, Yuh-Chin T

dc.date.accessioned

2021-01-26T23:10:51Z

dc.date.available

2021-01-26T23:10:51Z

dc.date.issued

2004-02

dc.date.updated

2021-01-26T23:10:51Z

dc.description.abstract

Exposure to excessive vanadium occurs in some occupations and with consumption of some dietary regimens for weight reduction and body building. Because vanadium is vasoactive, individuals exposed to excessive vanadium may develop adverse vascular effects. We have previously shown that vanadyl sulfate causes acute pulmonary vasoconstriction, which could be attributed in part to inhibition of nitric oxide production. In the present study we investigated whether NO inhibition was related to phosphorylation of endothelial nitric oxide synthase (eNOS). VOSO4 produced dose-dependent constriction of pulmonary arteries in isolated perfused lungs and pulmonary arterial rings and a right shift of the acetylcholine-dependent vasorelaxation curve. VOSO4 inhibited constitutive as well as A23187-stimulated NO production. Constitutive NO inhibition was accompanied by increased Thr495 (threonine at codon 495) phosphorylation of eNOS, which would inhibit eNOS activity. Thr495 phosphorylation of eNOS and inhibition of NO were partially reversed by pretreatment with calphostin C, a protein kinase C (PKC) inhibitor. There were no changes in Ser1177 (serine at codon 1177) or tyrosine phosphorylation of eNOS. These results indicate that VOSO4 induced acute pulmonary vasoconstriction that was mediated in part by the inhibition of endothelial NO production via PKC-dependent phosphorylation of Thr495 of eNOS. Exposure to excessive vanadium may contribute to pulmonary vascular diseases.

dc.identifier.issn

0091-6765

dc.identifier.issn

1552-9924

dc.identifier.uri

https://hdl.handle.net/10161/22252

dc.language

eng

dc.publisher

Environmental Health Perspectives

dc.relation.ispartof

Environmental health perspectives

dc.relation.isversionof

10.1289/ehp.6477

dc.subject

Lung

dc.subject

Animals

dc.subject

Rabbits

dc.subject

Humans

dc.subject

Lung Diseases

dc.subject

Vanadium

dc.subject

Nitric Oxide

dc.subject

Vanadium Compounds

dc.subject

Threonine

dc.subject

Hypoglycemic Agents

dc.subject

Organ Culture Techniques

dc.subject

Occupational Exposure

dc.subject

Phosphorylation

dc.subject

Vasoconstriction

dc.subject

Dose-Response Relationship, Drug

dc.subject

Male

dc.subject

Nitric Oxide Synthase

dc.title

Vanadyl sulfate inhibits NO production via threonine phosphorylation of eNOS.

dc.type

Journal article

pubs.begin-page

201

pubs.end-page

206

pubs.issue

2

pubs.organisational-group

School of Medicine

pubs.organisational-group

Medicine, Pulmonary, Allergy, and Critical Care Medicine

pubs.organisational-group

Duke

pubs.organisational-group

Medicine

pubs.organisational-group

Clinical Science Departments

pubs.publication-status

Published

pubs.volume

112

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Vanadyl sulfate inhibits NO production via threonine phosphorylation of eNOS.pdf
Size:
175.07 KB
Format:
Adobe Portable Document Format